This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Nov 1;384(9954):1557-60.

doi: 10.1016/S0140-6736(14)61225-3. Epub 2014 Jul 28.

Hepatitis C beware--the end is nigh

Ed Gane¹

Affiliations

Affiliation

¹ New Zealand Liver Transplant Unit, Auckland City Hospital, Grafton, Auckland 1142, New Zealand; Faculty of Medicine, University of Auckland, Auckland, New Zealand. Electronic address: edgane@adhb.govt.nz.

PMID: 25078308
DOI: 10.1016/S0140-6736(14)61225-3

Comment

Hepatitis C beware--the end is nigh

Ed Gane. Lancet. 2014.

. 2014 Nov 1;384(9954):1557-60.

doi: 10.1016/S0140-6736(14)61225-3. Epub 2014 Jul 28.

Author

Ed Gane¹

Affiliation

¹ New Zealand Liver Transplant Unit, Auckland City Hospital, Grafton, Auckland 1142, New Zealand; Faculty of Medicine, University of Auckland, Auckland, New Zealand. Electronic address: edgane@adhb.govt.nz.

PMID: 25078308
DOI: 10.1016/S0140-6736(14)61225-3

No abstract available

PubMed Disclaimer

Comment on

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.
Manns M, Pol S, Jacobson IM, Marcellin P, Gordon SC, Peng CY, Chang TT, Everson GT, Heo J, Gerken G, Yoffe B, Towner WJ, Bourliere M, Metivier S, Chu CJ, Sievert W, Bronowicki JP, Thabut D, Lee YJ, Kao JH, McPhee F, Kopit J, Mendez P, Linaberry M, Hughes E, Noviello S; HALLMARK-DUAL Study Team. Manns M, et al. Lancet. 2014 Nov 1;384(9954):1597-605. doi: 10.1016/S0140-6736(14)61059-X. Epub 2014 Jul 28. Lancet. 2014. PMID: 25078304 Clinical Trial.

Similar articles

Successful treatment of post-transplant hepatitis C virus cirrhosis with daclatasvir and asunaprevir.
Ozaras R, Mete B, Yemisen M, Balkan II, Alkan M, Tabak F. Ozaras R, et al. J Gastrointestin Liver Dis. 2015 Sep;24(3):393-4. J Gastrointestin Liver Dis. 2015. PMID: 26405716 No abstract available.
[Combined therapy with daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b: a case report].
Pi SN, Chen YP. Pi SN, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Aug 20;36(8):1163-4. Nan Fang Yi Ke Da Xue Xue Bao. 2016. PMID: 27578593 Chinese.
Case of psoriatic patient who maintains long-term remission after anti-hepatitis C virus agents and ustekinumab treatment.
Kikuchi S, Umezawa Y, Chihara M, Asahina A, Nakagawa H. Kikuchi S, et al. J Dermatol. 2018 Mar;45(3):e59-e60. doi: 10.1111/1346-8138.14229. Epub 2018 Jan 31. J Dermatol. 2018. PMID: 29388245 No abstract available.
Asunaprevir for hepatitis C: a safety evaluation.
Gentile I, Zappulo E, Buonomo AR, Scotto R, Borgia G. Gentile I, et al. Expert Opin Drug Saf. 2015 Oct;14(10):1631-46. doi: 10.1517/14740338.2015.1084287. Epub 2015 Sep 2. Expert Opin Drug Saf. 2015. PMID: 26329454 Review.
The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevir.
Hayes CN, Imamura M, Chayama K. Hayes CN, et al. Expert Rev Gastroenterol Hepatol. 2017 Feb;11(2):103-113. doi: 10.1080/17474124.2017.1270205. Epub 2016 Dec 16. Expert Rev Gastroenterol Hepatol. 2017. PMID: 27936974 Review.

See all similar articles

Cited by

Excitable models: Projections, targets, and the making of futures without disease.
Rhodes T, Lancaster K. Rhodes T, et al. Sociol Health Illn. 2021 May;43(4):859-880. doi: 10.1111/1467-9566.13263. Epub 2021 May 4. Sociol Health Illn. 2021. PMID: 33942914 Free PMC article.
Synergistic Activity of Combined NS5A Inhibitors.
O'Boyle DR 2nd, Nower PT, Gao M, Fridell R, Wang C, Hewawasam P, Lopez O, Tu Y, Meanwell NA, Belema M, Roberts SB, Cockett M, Sun JH. O'Boyle DR 2nd, et al. Antimicrob Agents Chemother. 2015 Dec 28;60(3):1573-83. doi: 10.1128/AAC.02639-15. Antimicrob Agents Chemother. 2015. PMID: 26711745 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations